06/25/2012 - 10:31am

The Food and Drug Administration has approved a generic drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Monday.

06/25/2012 - 9:17am

Teva has launched a generic version of an Eli Lilly drug.

06/21/2012 - 11:42am

Coca-Cola announced it will distribute a dairy product that is produced and marketed by Fair Oaks Farms Brands, a collective of American family farmers.

06/21/2012 - 11:15am

Lansinoh Labs has partnered with TheraPearl to create a first-of-its-kind solution for breast-feeding moms that delivers 360 degrees of relief in a unique cold, warm and hot therapy pack that conforms to the breast.

06/21/2012 - 9:15am

The Food and Drug Administration has approved a new indication for a Pfizer drug.

06/18/2012 - 12:21pm

HealthNet on Monday released its PillManager mobile application across both Apple and Android platforms. The app allows consumers to track their own medication schedules and interact directly with their doctor or pharmacist for repeat prescriptions.

06/18/2012 - 11:59am

Greenstone, the generic pharmaceutical subsidiary of Pfizer, has launched olanzapine tablets.

06/15/2012 - 11:08am

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

06/14/2012 - 12:47pm

Kadmon Pharmaceuticals earlier this month announced that it has launched a new 600 mg/day dose pack of Ribasphere RibaPak (ribavirin, USP), Kadmon's proprietary ribavirin regimen available in a daily, two-pill compliance package for enhanced therapy adherence.